In NDCs, both CD19+ ASC and total ASC/B-cell ratios did not differ between blood and CNS compartments (Fig. 1c and d), suggesting a local shift in B-cell maturation towards ASCs in MS but not control donors. This evidence concerns the gene CD19 and myeloid sarcoma.